Stanford University School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT00186563
This study aims to establish a novel approach assisting the rational development of analgesic and anti-inflammatory drugs. In a first step we will test in healthy human volunteers whether proteins mediating inflammation and pain can be detected in an experimentally induced inflammatory skin lesion. Fluids that will be used to detect such proteins will be collected from the inflamed skin site via small porous catheters. We wish to establish the expression pattern of different proteins and correlate it with various tests assessing pain.
Looking for future studies?
Notify Me21 year–60 year
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1. Age between 21-60. 2. Skin type II or III according to the classification of Fitzpatrick (II: fair skin, always burns, sometimes tans, III: medium skin, sometimes burns, always tans).
 Exclusion Criteria:1. History of a significant systemic disease, a dermatological disease, bleeding disorder, or chronic pain.
Martin Angst
Other
Proof-of-concept Study for Bio-marker Assay Validation in Humans
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06279143
BCC, BCC - Basal Cell Carcinoma
Vejle, Region of Southern Danmark, Denmark
View Trial DetailsNCT06092866
Digestive System Diseases, Gastro-Intestinal Disorder
Malmö, Region Skane, Sweden
View Trial DetailsNCT06237036
Chronic Disease, Disease Attributes
Torrejón de Ardoz, Madrid, Spain
View Trial DetailsNCT01865032
Euglenozoa Infections, Infections
New York, United States
View Trial Details